EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Pathogenic Role of C-Reactive Protein in Diabetes-Linked Unstable Atherosclerosis

Melania Sibianu, Mark Slevin iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26146855 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Melania Sibianu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral School of Medicine and Pharmacy, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, 38th Gh. Marine…. Hauptthemen laut MEDLINE: Atherosclerosis, C-Reactive Protein, Diabetes Mellitus. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

C-reactive protein (CRP) has long been recognized as a biomarker of systemic inflammation and cardiovascular disease (CVD) risk. However, emerging evidence highlights the distinct and potent pro-inflammatory role of its monomeric form (mCRP), which is predominantly tissue-bound and directly implicated in vascular injury and plaque destabilization. This narrative review explores the interactions and overlapping pathways that converge within and modulate CRP, mCRP, the associated pathophysiology of diabetes mellitus, and cardiovascular disease. We examine how mCRP promotes endothelial dysfunction, leukocyte recruitment, platelet activation, and macrophage polarization, thereby contributing to the formation of unstable atherosclerotic plaques. Furthermore, we discuss the critical influence of diabetes in amplifying mCRP’s pathogenic effects through metabolic dysregulation, chronic hyperglycemia, and enhanced formation of advanced glycation end products (AGEs). The synergistic interaction of mCRP with the AGE-receptor for AGE (RAGE) axis exacerbates oxidative stress and vascular inflammation, accelerating atherosclerosis progression and increasing cardiovascular risk in diabetic patients. Understanding these mechanistic pathways implicates mCRP as both a biomarker and therapeutic target, particularly in the context of diabetes-associated CVD. This review highlights the need for further research into targeted interventions that disrupt the mCRP-[AGE-RAGE] inflammatory cycle to reduce plaque instability and improve cardiovascular outcomes in high-risk populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtherosclerosisC-Reactive ProteinDiabetes MellitusHumansAnimalsBiomarkersGlycation End Products, AdvancedInflammationOxidative StressPlaque, Atherosclerotic

Stichwörter der Autor:innen

AGE-RAGECRPatherosclerosisdiabetesinflammationmonomeric-CRP

Substanzen

C-Reactive ProteinBiomarkersGlycation End Products, Advanced

Autor:innen und Institutionen

  • Doctoral School of Medicine and Pharmacy, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, 38th Gh. Marinescu Street, 540139 Târgu Mureş, Romania.
  • Center for Advanced Medical and Pharmaceutical Research, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Târgu Mureș, 38th Gh. Marinescu Street, 540139 Târgu Mureş, Romania.

ORCID-Profile: Mark Slevin

Zitieren

APA

Sibianu, M., & Slevin, M. (2025). The Pathogenic Role of C-Reactive Protein in Diabetes-Linked Unstable Atherosclerosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26146855

Vancouver

Sibianu M, Slevin M. The Pathogenic Role of C-Reactive Protein in Diabetes-Linked Unstable Atherosclerosis. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26146855

BibTeX
@article{Sibianu2025,
  author = {Sibianu, Melania and Slevin, Mark},
  title = {The Pathogenic Role of C-Reactive Protein in Diabetes-Linked Unstable Atherosclerosis},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26146855}
}
Kostenlos starten →